Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/24550
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGyawali, R.
dc.contributor.authorBaral, A.
dc.contributor.authorUpreti, D.
dc.contributor.authorYadav, C.B.
dc.contributor.authorGupta, A.K.
dc.contributor.authorChandradasa, M.
dc.contributor.authorShoib, S.
dc.date.accessioned2022-03-25T07:40:52Z
dc.date.available2022-03-25T07:40:52Z
dc.date.issued2022
dc.identifier.citationArchives of Women's Mental Health.2022;25(3):671-674.[Epub 2022 Mar 14]en_US
dc.identifier.issn1434-1816
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/24550
dc.descriptionIndexed in MEDLINE.en_US
dc.description.abstractOlanzapine is widely used during pregnancy to manage mood and psychotic disorders with overall beneficial effects. There have been past reports of olanzapine exposure during early pregnancy and clubfoot in two newborns from India and Israel. We report a woman in Nepal diagnosed with schizophrenia and treated with olanzapine throughout the pregnancy delivering a baby boy with congenital talipes equinovarus deformity. Like in many other low-income settings, pregnancy was unplanned, and pre-conception counselling was not done. Research in mice has revealed the negative effects of olanzapine on bone development. Further reports would strengthen this potential association between exposure to olanzapine in the first trimester and the occurrence of clubfoot in the baby.en_US
dc.language.isoenen_US
dc.publisherSpringer,New Yorken_US
dc.subjectAntipsychotic Agentsen_US
dc.subjectClubfooten_US
dc.titleNovel report on congenital talipes equinovarus (CTEV) following olanzapine exposure during pregnancy: case report and short review.en_US
dc.typeArticleen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.